| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
GW Pharmaceuticals
|
Patent holder |
5
|
1 | |
|
person
U.S. Federal Government
|
Patent holder |
5
|
1 |
This document is page 84 of a 'Cannabis Investment Report' dated December 2017, published by Ackrell Capital, LLC. The text details the legal complexities of intellectual property protection for cannabis businesses, specifically discussing the USDA's Plant Variety Protection Act (PVPA) and the federal Trademark Act (Lanham Act). It highlights that federal trademark registration is generally unavailable for products that are illegal under federal law, though some ancillary products (like clothing) may be eligible. The page bears a 'HOUSE_OVERSIGHT_024720' stamp, indicating it was part of document production for a House Oversight Committee investigation.
This document is page 83 of a 2017 report by Ackrell Capital regarding the U.S. legal landscape for cannabis. It details the application of Section 280E of the tax code to cannabis businesses and discusses the Patent Act, listing several specific cannabis-related patents issued by the USPTO (including one held by the U.S. federal government) despite the drug's federal illegality. The document bears a House Oversight Committee Bates stamp, but contains no direct text references to Jeffrey Epstein or his associates on this specific page.
This document appears to be a page from a resource guide or business book (resembling the style of Tim Ferriss's 'The 4-Hour Workweek') contained within a House Oversight discovery file (Bates stamped HOUSE_OVERSIGHT_013905). It lists resources for entrepreneurs, including software for screen recording, contacts for licensing inventions (specifically highlighting Stephen Key and InventRight), and strategies for media exposure via HARO. The text provides specific phone numbers, websites, and financial benchmarks for licensing royalties and corporate revenues.
This document is page 174 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital, LLC. It serves as a glossary defining various terms and acronyms related to cannabis and international drug policy (e.g., UN, USDA, Vaporizer, Wax). The document bears the Bates stamp HOUSE_OVERSIGHT_024810, indicating it was part of a document production for the House Oversight Committee.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity